- 期刊
- OpenAccess
Multikinase inhibitors in the setting of thyroid carcinoma
延伸閱讀
- Rostan, G. G., Tallini, G., & Salvatore, G. (2015). Anaplastic Thyroid Carcinoma: Molecular Tools for Diagnosis and Therapy. International Journal of Endocrinology, 2015(), 712-713-077. https://doi.org/10.1155/2015/341725
- Giunti, S., Antonelli, A., Amorosi, A., & Santarpia, L. (2013). Cellular Signaling Pathway Alterations and Potential Targeted Therapies for Medullary Thyroid Carcinoma. International Journal of Endocrinology, 2013(), 634-649-173. https://doi.org/10.1155/2013/803171
- Pinchot, S. N., Kunnimalaiyaan, M., Sippel, R. S., & Chen, H. (2009). Medullary Thyroid Carcinoma: Targeted Therapies and Future Directions. Journal of Oncology, 2009(), 128-134. https://doi.org/10.1155/2009/183031
- Kobawala, T. P., Trivedi, T. I., Gajjar, K. K., Patel, D. H., Patel, G. H., & Ghosh, N. R. (2016). Significance of Interleukin-6 in Papillary Thyroid Carcinoma. Journal of Thyroid Research, 2016(), 54-65. https://doi.org/10.1155/2016/6178921
- Grande, E., Díez, J. J., Zafon, C., & Capdevila, J. (2012). Thyroid Cancer: Molecular Aspects and New Therapeutic Strategies. Journal of Thyroid Research, 2012(), 281-290. https://doi.org/10.1155/2012/847108